This activity is a case-based session with the goal of enhancing participants’ understanding of the moral theories underlying bioethics, and applying these theories to clinical cases that are relevant to radiation oncologists.
This multi-session course provides a practical, evidence-based overview of contemporary palliative radiation oncology, with a focus on optimizing symptom relief, treatment selection, and supportive care for patients with advanced malignancies.
The management of patients with brain metastases and leptomeningeal disease (LMD) presents complex clinical challenges requiring nuanced, evidence-based decision-making.
Palliative radiotherapy remains an unmet need, despite its efficacy. The presenter discusses how a dedicated palliative radiation service can address barriers to care and play an integral role in improving care access and receipt.
Radiation oncologists see patients across a wide spectrum of oncologic diseases and clinical conditions. Whether as a result of disease burden, cancer-directed treatment, or other unrelated problems, many patients present to radiation oncology clinic with significant symptom management needs.
This session provides an overview about palliative radiation for head and neck and skin malignancies. It focuses on a brief review of the available evidence supporting palliative radiation therapy for these diseases and help participants identify resources to help guide them in application.
This presentation reviews the role of radiation therapy in the management of non-spine bone metastases, focusing on patient evaluation, treatment intent, dose selection, and integration with systemic and surgical care.
This presentation focuses on the management of spine metastases with palliative radiation, emphasizing a multidisciplinary and patient-centered approach incorporating up-to-date clinical practice guidelines and evidence.
With technological advances re-irradiation has rapidly become common and an important part of cancer management to new or recurrent tumors, yet is clinically challenging given risks of serious toxicity from cumulative doses.